-
1
Chronic subthalamic nucleus deep brain stimulation reduces pathological TrkB aggregates in a Parkinson’s disease rat model
Published 2025-02-01“…Translational Neurodegeneration…”
Get full text
Article -
2
Second-generation anti-amyloid monoclonal antibodies for Alzheimer’s disease: current landscape and future perspectives
Published 2025-01-01“…Translational Neurodegeneration…”
Get full text
Article -
3
Abnormal α-synuclein binds to synaptotagmin 13, impairing extracellular vesicle release in synucleinopathies
Published 2025-06-01“…Translational Neurodegeneration…”
Get full text
Article -
4
Inhibition of SOD1 trimerization is a novel drug target for ALS disease
Published 2025-05-01“…Translational Neurodegeneration…”
Get full text
Article -
5
AMPA receptor diffusional trapping machinery as an early therapeutic target in neurodegenerative and neuropsychiatric disorders
Published 2025-02-01“…Translational Neurodegeneration…”
Get full text
Article -
6
TRPV1 alleviates APOE4-dependent microglial antigen presentation and T cell infiltration in Alzheimer's disease
Published 2024-10-01“…Translational Neurodegeneration…”
Get full text
Article -
7
Progranulin deficiency in the brain: the interplay between neuronal and non-neuronal cells
Published 2025-04-01“…Translational Neurodegeneration…”
Get full text
Article -
8
Controversies and insights into PTBP1-related astrocyte-neuron transdifferentiation: neuronal regeneration strategies for Parkinson’s and Alzheimer’s disease
Published 2024-12-01“…Translational Neurodegeneration…”
Get full text
Article -
9
Refining α-synuclein seed amplification assays to distinguish Parkinson’s disease from multiple system atrophy
Published 2025-02-01“…Translational Neurodegeneration…”
Get full text
Article -
10
Inflammasomes in neurodegenerative diseases
Published 2024-12-01“…Translational Neurodegeneration…”
Get full text
Article -
11
Nootropic foods in neurodegenerative diseases: mechanisms, challenges, and future
Published 2025-04-01“…Translational Neurodegeneration…”
Get full text
Article -
12
Enhanced serum-based seed amplification assay for detecting propagative α-synuclein seeds in Parkinson’s disease
Published 2025-05-01“…Translational Neurodegeneration…”
Get full text
Article -
13
Dorsal hyperintensity and iron deposition patterns in the substantia nigra of Parkinson’s disease, idiopathic REM sleep behavior disorder, and Parkinson-plus syndromes at 7T MRI: a...
Published 2025-07-01“…Translational Neurodegeneration…”
Get full text
Article -
14
Critical role of ROCK1 in AD pathogenesis via controlling lysosomal biogenesis and acidification
Published 2024-11-01“…Translational Neurodegeneration…”
Get full text
Article -
15
Psychoactive substances: novel molecular insights and therapeutic potential for Alzheimer's disease
Published 2025-07-01“…Translational Neurodegeneration…”
Get full text
Article -
16
Axonal tau reduction ameliorates tau and amyloid pathology in a mouse model of Alzheimer’s disease
Published 2025-07-01“…Translational Neurodegeneration…”
Get full text
Article -
17
Enhanced prefrontal nicotinic signaling as evidence of active compensation in Alzheimer’s disease models
Published 2024-12-01“…Translational Neurodegeneration…”
Get full text
Article -
18
Cell-specific copper dyshomeostasis mechanism in Alzheimer’s disease
Published 2025-08-01“…Translational Neurodegeneration…”
Get full text
Article -
19
Aging-dependent YAP1 reduction contributes to AD pathology by upregulating the Nr4a1-AKT/GSK-3β axis
Published 2025-06-01“…Translational Neurodegeneration…”
Get full text
Article -
20
Extracellular PHF-tau modulates astrocyte mitochondrial dynamics and mediates neuronal connectivity
Published 2025-03-01“…Translational Neurodegeneration…”
Get full text
Article